Not to be sniffed at! Nasal spray could end painful dentist injections

Kovacaine Mist was as effective as standard anaesthetics in four out of five patients

Charlie Cooper
Thursday 04 July 2013 13:44 EDT
Comments
Good news for patients who dread the dentist's needle
Good news for patients who dread the dentist's needle (Getty Images)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Good news for patients who dread the dentist's needle - scientists in America have pioneered a nasal spray that could do away with painful anaesthetic injections for most procedures.

The spray, Kovacaine Mist, was as effective as standard anaesthetics in four out of five patients, according to researchers at the University of Buffalo. Around 15 million people in the UK have "dental anxiety" according to the British Dental Association.

Dr Nigel Carter, chief executive of the British Dental Health Foundation said: "Patients anxious of the dentist are, in theory, likely to have poorer oral health than those who get regular check-ups. This nasal spray could be a very promising addition to any dental practice."

The product has passed phase two clinical trials in the USA. Safety trials with the US Food and Drugs Administration could be complete by the end of the summer and final product approval in the USA could be achieved by next year, according to the manufacturer, St Renatus LLC.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in